1h Free Analyst Time
The global vertigo drugs market is forecasted to grow by USD 682.2 million during 2025-2030, accelerating at a CAGR of 5.9% during the forecast period. The report on the global vertigo drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising demand for vertigo drugs in emerging economies, increasing healthcare facilities in developing nations, increased penetration of online channels.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global vertigo drugs market is segmented as below:
By Type
- Peripheral vertigo
- Central vertigo
By Distribution Channel
- Offline
- Online
By Route Of Administration
- Oral
- Injectable
By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- The Netherlands
- Spain
- Russia
- Asia
- Rest of World (RoW)
The report on the global vertigo drugs market covers the following areas:
- Global vertigo drugs market sizing
- Global vertigo drugs market forecast
- Global vertigo drugs market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Vertigo Drugs Market 2020 - 2024
- Historic Market Size - Data Table on Global Vertigo Drugs Market 2020 - 2024 ($ million)
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
- Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on global vertigo drugs market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Type
8.1 Market segments
- Chart on Type - Market share 2025-2030 (%)
- Data Table on Type - Market share 2025-2030 (%)
- Chart on Comparison by Type
- Data Table on Comparison by Type
- Chart on Peripheral vertigo - Market size and forecast 2025-2030 ($ million)
- Data Table on Peripheral vertigo - Market size and forecast 2025-2030 ($ million)
- Chart on Peripheral vertigo - Year-over-year growth 2025-2030 (%)
- Data Table on Peripheral vertigo - Year-over-year growth 2025-2030 (%)
- Chart on Central vertigo - Market size and forecast 2025-2030 ($ million)
- Data Table on Central vertigo - Market size and forecast 2025-2030 ($ million)
- Chart on Central vertigo - Year-over-year growth 2025-2030 (%)
- Data Table on Central vertigo - Year-over-year growth 2025-2030 (%)
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Distribution Channel
9.1 Market segments
- Chart on Distribution Channel - Market share 2025-2030 (%)
- Data Table on Distribution Channel - Market share 2025-2030 (%)
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- Chart on Offline - Market size and forecast 2025-2030 ($ million)
- Data Table on Offline - Market size and forecast 2025-2030 ($ million)
- Chart on Offline - Year-over-year growth 2025-2030 (%)
- Data Table on Offline - Year-over-year growth 2025-2030 (%)
- Chart on Online - Market size and forecast 2025-2030 ($ million)
- Data Table on Online - Market size and forecast 2025-2030 ($ million)
- Chart on Online - Year-over-year growth 2025-2030 (%)
- Data Table on Online - Year-over-year growth 2025-2030 (%)
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)
10 Market Segmentation by Route of Administration
10.1 Market segments
- Chart on Route of Administration - Market share 2025-2030 (%)
- Data Table on Route of Administration - Market share 2025-2030 (%)
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- Chart on Oral - Market size and forecast 2025-2030 ($ million)
- Data Table on Oral - Market size and forecast 2025-2030 ($ million)
- Chart on Oral - Year-over-year growth 2025-2030 (%)
- Data Table on Oral - Year-over-year growth 2025-2030 (%)
- Chart on Injectable - Market size and forecast 2025-2030 ($ million)
- Data Table on Injectable - Market size and forecast 2025-2030 ($ million)
- Chart on Injectable - Year-over-year growth 2025-2030 (%)
- Data Table on Injectable - Year-over-year growth 2025-2030 (%)
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
11 Customer Landscape
11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ million)
- Data Table on US - Market size and forecast 2025-2030 ($ million)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ million)
- Data Table on Canada - Market size and forecast 2025-2030 ($ million)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ million)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2025-2030 ($ million)
- Data Table on Germany - Market size and forecast 2025-2030 ($ million)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on UK - Market size and forecast 2025-2030 ($ million)
- Data Table on UK - Market size and forecast 2025-2030 ($ million)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ million)
- Data Table on France - Market size and forecast 2025-2030 ($ million)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ million)
- Data Table on Italy - Market size and forecast 2025-2030 ($ million)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ million)
- Data Table on Spain - Market size and forecast 2025-2030 ($ million)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on Russia - Market size and forecast 2025-2030 ($ million)
- Data Table on Russia - Market size and forecast 2025-2030 ($ million)
- Chart on Russia - Year-over-year growth 2025-2030 (%)
- Data Table on Russia - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2025-2030 ($ million)
- Data Table on China - Market size and forecast 2025-2030 ($ million)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on Japan - Market size and forecast 2025-2030 ($ million)
- Data Table on Japan - Market size and forecast 2025-2030 ($ million)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ million)
- Data Table on India - Market size and forecast 2025-2030 ($ million)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ million)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
- Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
- Chart on Indonesia - Year-over-year growth 2025-2030 (%)
- Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
- Chart on Thailand - Market size and forecast 2025-2030 ($ million)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- Chart on Singapore - Market size and forecast 2025-2030 ($ million)
- Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
- Chart on Singapore - Year-over-year growth 2025-2030 (%)
- Data Table on Singapore - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Australia - Market size and forecast 2025-2030 ($ million)
- Data Table on Australia - Market size and forecast 2025-2030 ($ million)
- Chart on Australia - Year-over-year growth 2025-2030 (%)
- Data Table on Australia - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ million)
- Data Table on UAE - Market size and forecast 2025-2030 ($ million)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on Brazil - Market size and forecast 2025-2030 ($ million)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ million)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on Turkey - Market size and forecast 2025-2030 ($ million)
- Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
- Chart on Turkey - Year-over-year growth 2025-2030 (%)
- Data Table on Turkey - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
- Rising demand for vertigo drugs in emerging economies
- Increasing healthcare facilities in developing nations
- Increased penetration of online channels
- Presence of generic drugs for vertigo
- Poor knowledge of treatment options for vertigo
- Side effects of vertigo drugs
- Impact of drivers and challenges in 2025 and 2030
- Integration of digital health solutions in vertigo
- Launch of new vertigo drugs
- Increasing research and development by pharmaceutical companies
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- AdvaCare Pharma - Overview
- AdvaCare Pharma - Product / Service
- AdvaCare Pharma - Key offerings
- SWOT
- Amneal Pharmaceuticals Inc. - Overview
- Amneal Pharmaceuticals Inc. - Business segments
- Amneal Pharmaceuticals Inc. - Key news
- Amneal Pharmaceuticals Inc. - Key offerings
- Amneal Pharmaceuticals Inc. - Segment focus
- SWOT
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- SWOT
- Epic Pharma LLC - Overview
- Epic Pharma LLC - Product / Service
- Epic Pharma LLC - Key offerings
- SWOT
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT
- Intas Pharmaceuticals Ltd. - Overview
- Intas Pharmaceuticals Ltd. - Product / Service
- Intas Pharmaceuticals Ltd. - Key offerings
- SWOT
- Jubilant Life Sciences Ltd. - Overview
- Jubilant Life Sciences Ltd. - Product / Service
- Jubilant Life Sciences Ltd. - Key offerings
- SWOT
- Lupin Ltd. - Overview
- Lupin Ltd. - Business segments
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
- Lupin Ltd. - Segment focus
- SWOT
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
- Sun Pharmaceutical Industries Ltd. - Overview
- Sun Pharmaceutical Industries Ltd. - Product / Service
- Sun Pharmaceutical Industries Ltd. - Key news
- Sun Pharmaceutical Industries Ltd. - Key offerings
- SWOT
- Teva Pharmaceutical Ltd. - Overview
- Teva Pharmaceutical Ltd. - Business segments
- Teva Pharmaceutical Ltd. - Key news
- Teva Pharmaceutical Ltd. - Key offerings
- Teva Pharmaceutical Ltd. - Segment focus
- SWOT
- Zydus Lifesciences Ltd. - Overview
- Zydus Lifesciences Ltd. - Business segments
- Zydus Lifesciences Ltd. - Key news
- Zydus Lifesciences Ltd. - Key offerings
- Zydus Lifesciences Ltd. - Segment focus
- SWOT
16 Appendix
16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Type
Exhibit 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Vertigo Drugs Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Type Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Type - Market share 2025-2030 (%)
Exhibit 39: Data Table on Type - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Type
Exhibit 41: Data Table on Comparison by Type
Exhibit 42: Chart on Peripheral vertigo - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Peripheral vertigo - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Peripheral vertigo - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Peripheral vertigo - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Central vertigo - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Central vertigo - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Central vertigo - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Central vertigo - Year-over-year growth 2025-2030 (%)
Exhibit 50: Market opportunity by Type ($ million)
Exhibit 51: Data Table on Market opportunity by Type ($ million)
Exhibit 52: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 53: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 54: Chart on Comparison by Distribution Channel
Exhibit 55: Data Table on Comparison by Distribution Channel
Exhibit 56: Chart on Offline - Market size and forecast 2025-2030 ($ million)
Exhibit 57: Data Table on Offline - Market size and forecast 2025-2030 ($ million)
Exhibit 58: Chart on Offline - Year-over-year growth 2025-2030 (%)
Exhibit 59: Data Table on Offline - Year-over-year growth 2025-2030 (%)
Exhibit 60: Chart on Online - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Online - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Online - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Online - Year-over-year growth 2025-2030 (%)
Exhibit 64: Market opportunity by Distribution Channel ($ million)
Exhibit 65: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 66: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 67: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 68: Chart on Comparison by Route of Administration
Exhibit 69: Data Table on Comparison by Route of Administration
Exhibit 70: Chart on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 71: Data Table on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 72: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 73: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 74: Chart on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibit 75: Data Table on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibit 76: Chart on Injectable - Year-over-year growth 2025-2030 (%)
Exhibit 77: Data Table on Injectable - Year-over-year growth 2025-2030 (%)
Exhibit 78: Market opportunity by Route of Administration ($ million)
Exhibit 79: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 80: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 81: Chart on Market share by geography 2025-2030 (%)
Exhibit 82: Data Table on Market share by geography 2025-2030 (%)
Exhibit 83: Chart on Geographic comparison
Exhibit 84: Data Table on Geographic comparison
Exhibit 85: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 86: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 88: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 89: Chart on Regional Comparison - North America
Exhibit 90: Data Table on Regional Comparison - North America
Exhibit 91: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 92: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 93: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 95: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 96: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 97: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 98: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 99: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 100: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 101: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 102: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 103: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 104: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 105: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 106: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 107: Chart on Regional Comparison - Europe
Exhibit 108: Data Table on Regional Comparison - Europe
Exhibit 109: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 110: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 111: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 112: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 113: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 114: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 115: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 116: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 117: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 118: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 119: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 120: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 121: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 122: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 123: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 124: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 125: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 126: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 128: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 129: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Regional Comparison - Asia
Exhibit 142: Data Table on Regional Comparison - Asia
Exhibit 143: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 144: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 145: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 146: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 147: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 148: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 149: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 150: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 151: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 152: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 153: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 154: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 155: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 156: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 176: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 177: Chart on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 178: Data Table on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 179: Chart on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 180: Data Table on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 181: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 182: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 183: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 184: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 185: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 186: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 187: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 201: Market opportunity by geography ($ million)
Exhibit 202: Data Tables on Market opportunity by geography ($ million)
Exhibit 203: Impact of drivers and challenges in 2025 and 2030
Exhibit 204: Overview on criticality of inputs and factors of differentiation
Exhibit 205: Overview on factors of disruption
Exhibit 206: Impact of key risks on business
Exhibit 207: Companies covered
Exhibit 208: Company ranking index
Exhibit 209: Matrix on companies position and classification
Exhibit 210: AdvaCare Pharma - Overview
Exhibit 211: AdvaCare Pharma - Product / Service
Exhibit 212: AdvaCare Pharma - Key offerings
Exhibit 213: SWOT
Exhibit 214: Amneal Pharmaceuticals Inc. - Overview
Exhibit 215: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 216: Amneal Pharmaceuticals Inc. - Key news
Exhibit 217: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 218: Amneal Pharmaceuticals Inc. - Segment focus
Exhibit 219: SWOT
Exhibit 220: AstraZeneca Plc - Overview
Exhibit 221: AstraZeneca Plc - Product / Service
Exhibit 222: AstraZeneca Plc - Key news
Exhibit 223: AstraZeneca Plc - Key offerings
Exhibit 224: SWOT
Exhibit 225: Epic Pharma LLC - Overview
Exhibit 226: Epic Pharma LLC - Product / Service
Exhibit 227: Epic Pharma LLC - Key offerings
Exhibit 228: SWOT
Exhibit 229: F. Hoffmann La Roche Ltd. - Overview
Exhibit 230: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 231: F. Hoffmann La Roche Ltd. - Key news
Exhibit 232: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 233: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 234: SWOT
Exhibit 235: GlaxoSmithKline Plc - Overview
Exhibit 236: GlaxoSmithKline Plc - Business segments
Exhibit 237: GlaxoSmithKline Plc - Key news
Exhibit 238: GlaxoSmithKline Plc - Key offerings
Exhibit 239: GlaxoSmithKline Plc - Segment focus
Exhibit 240: SWOT
Exhibit 241: Intas Pharmaceuticals Ltd. - Overview
Exhibit 242: Intas Pharmaceuticals Ltd. - Product / Service
Exhibit 243: Intas Pharmaceuticals Ltd. - Key offerings
Exhibit 244: SWOT
Exhibit 245: Jubilant Life Sciences Ltd. - Overview
Exhibit 246: Jubilant Life Sciences Ltd. - Product / Service
Exhibit 247: Jubilant Life Sciences Ltd. - Key offerings
Exhibit 248: SWOT
Exhibit 249: Lupin Ltd. - Overview
Exhibit 250: Lupin Ltd. - Business segments
Exhibit 251: Lupin Ltd. - Key news
Exhibit 252: Lupin Ltd. - Key offerings
Exhibit 253: Lupin Ltd. - Segment focus
Exhibit 254: SWOT
Exhibit 255: Novartis AG - Overview
Exhibit 256: Novartis AG - Business segments
Exhibit 257: Novartis AG - Key news
Exhibit 258: Novartis AG - Key offerings
Exhibit 259: Novartis AG - Segment focus
Exhibit 260: SWOT
Exhibit 261: Pfizer Inc. - Overview
Exhibit 262: Pfizer Inc. - Product / Service
Exhibit 263: Pfizer Inc. - Key news
Exhibit 264: Pfizer Inc. - Key offerings
Exhibit 265: SWOT
Exhibit 266: Sanofi SA - Overview
Exhibit 267: Sanofi SA - Business segments
Exhibit 268: Sanofi SA - Key news
Exhibit 269: Sanofi SA - Key offerings
Exhibit 270: Sanofi SA - Segment focus
Exhibit 271: SWOT
Exhibit 272: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 273: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 274: Sun Pharmaceutical Industries Ltd. - Key news
Exhibit 275: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibit 276: SWOT
Exhibit 277: Teva Pharmaceutical Ltd. - Overview
Exhibit 278: Teva Pharmaceutical Ltd. - Business segments
Exhibit 279: Teva Pharmaceutical Ltd. - Key news
Exhibit 280: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 281: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 282: SWOT
Exhibit 283: Zydus Lifesciences Ltd. - Overview
Exhibit 284: Zydus Lifesciences Ltd. - Business segments
Exhibit 285: Zydus Lifesciences Ltd. - Key news
Exhibit 286: Zydus Lifesciences Ltd. - Key offerings
Exhibit 287: Zydus Lifesciences Ltd. - Segment focus
Exhibit 288: SWOT
Exhibit 289: Inclusions checklist
Exhibit 290: Exclusions checklist
Exhibit 291: Currency conversion rates for US$
Exhibit 292: Research methodology
Exhibit 293: Information sources
Exhibit 294: Data validation
Exhibit 295: Validation techniques employed for market sizing
Exhibit 296: Data synthesis
Exhibit 297: 360 degree market analysis
Exhibit 298: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Type
Exhibit 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Vertigo Drugs Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Type Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Type - Market share 2025-2030 (%)
Exhibit 39: Data Table on Type - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Type
Exhibit 41: Data Table on Comparison by Type
Exhibit 42: Chart on Peripheral vertigo - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Peripheral vertigo - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Peripheral vertigo - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Peripheral vertigo - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Central vertigo - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Central vertigo - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Central vertigo - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Central vertigo - Year-over-year growth 2025-2030 (%)
Exhibit 50: Market opportunity by Type ($ million)
Exhibit 51: Data Table on Market opportunity by Type ($ million)
Exhibit 52: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 53: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 54: Chart on Comparison by Distribution Channel
Exhibit 55: Data Table on Comparison by Distribution Channel
Exhibit 56: Chart on Offline - Market size and forecast 2025-2030 ($ million)
Exhibit 57: Data Table on Offline - Market size and forecast 2025-2030 ($ million)
Exhibit 58: Chart on Offline - Year-over-year growth 2025-2030 (%)
Exhibit 59: Data Table on Offline - Year-over-year growth 2025-2030 (%)
Exhibit 60: Chart on Online - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Online - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Online - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Online - Year-over-year growth 2025-2030 (%)
Exhibit 64: Market opportunity by Distribution Channel ($ million)
Exhibit 65: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 66: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 67: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 68: Chart on Comparison by Route of Administration
Exhibit 69: Data Table on Comparison by Route of Administration
Exhibit 70: Chart on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 71: Data Table on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 72: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 73: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 74: Chart on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibit 75: Data Table on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibit 76: Chart on Injectable - Year-over-year growth 2025-2030 (%)
Exhibit 77: Data Table on Injectable - Year-over-year growth 2025-2030 (%)
Exhibit 78: Market opportunity by Route of Administration ($ million)
Exhibit 79: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 80: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 81: Chart on Market share by geography 2025-2030 (%)
Exhibit 82: Data Table on Market share by geography 2025-2030 (%)
Exhibit 83: Chart on Geographic comparison
Exhibit 84: Data Table on Geographic comparison
Exhibit 85: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 86: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 88: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 89: Chart on Regional Comparison - North America
Exhibit 90: Data Table on Regional Comparison - North America
Exhibit 91: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 92: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 93: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 95: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 96: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 97: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 98: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 99: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 100: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 101: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 102: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 103: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 104: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 105: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 106: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 107: Chart on Regional Comparison - Europe
Exhibit 108: Data Table on Regional Comparison - Europe
Exhibit 109: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 110: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 111: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 112: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 113: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 114: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 115: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 116: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 117: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 118: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 119: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 120: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 121: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 122: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 123: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 124: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 125: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 126: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 128: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 129: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Regional Comparison - Asia
Exhibit 142: Data Table on Regional Comparison - Asia
Exhibit 143: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 144: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 145: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 146: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 147: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 148: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 149: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 150: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 151: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 152: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 153: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 154: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 155: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 156: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 176: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 177: Chart on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 178: Data Table on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 179: Chart on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 180: Data Table on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 181: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 182: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 183: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 184: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 185: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 186: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 187: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 201: Market opportunity by geography ($ million)
Exhibit 202: Data Tables on Market opportunity by geography ($ million)
Exhibit 203: Impact of drivers and challenges in 2025 and 2030
Exhibit 204: Overview on criticality of inputs and factors of differentiation
Exhibit 205: Overview on factors of disruption
Exhibit 206: Impact of key risks on business
Exhibit 207: Companies covered
Exhibit 208: Company ranking index
Exhibit 209: Matrix on companies position and classification
Exhibit 210: AdvaCare Pharma - Overview
Exhibit 211: AdvaCare Pharma - Product / Service
Exhibit 212: AdvaCare Pharma - Key offerings
Exhibit 213: SWOT
Exhibit 214: Amneal Pharmaceuticals Inc. - Overview
Exhibit 215: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 216: Amneal Pharmaceuticals Inc. - Key news
Exhibit 217: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 218: Amneal Pharmaceuticals Inc. - Segment focus
Exhibit 219: SWOT
Exhibit 220: AstraZeneca Plc - Overview
Exhibit 221: AstraZeneca Plc - Product / Service
Exhibit 222: AstraZeneca Plc - Key news
Exhibit 223: AstraZeneca Plc - Key offerings
Exhibit 224: SWOT
Exhibit 225: Epic Pharma LLC - Overview
Exhibit 226: Epic Pharma LLC - Product / Service
Exhibit 227: Epic Pharma LLC - Key offerings
Exhibit 228: SWOT
Exhibit 229: F. Hoffmann La Roche Ltd. - Overview
Exhibit 230: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 231: F. Hoffmann La Roche Ltd. - Key news
Exhibit 232: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 233: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 234: SWOT
Exhibit 235: GlaxoSmithKline Plc - Overview
Exhibit 236: GlaxoSmithKline Plc - Business segments
Exhibit 237: GlaxoSmithKline Plc - Key news
Exhibit 238: GlaxoSmithKline Plc - Key offerings
Exhibit 239: GlaxoSmithKline Plc - Segment focus
Exhibit 240: SWOT
Exhibit 241: Intas Pharmaceuticals Ltd. - Overview
Exhibit 242: Intas Pharmaceuticals Ltd. - Product / Service
Exhibit 243: Intas Pharmaceuticals Ltd. - Key offerings
Exhibit 244: SWOT
Exhibit 245: Jubilant Life Sciences Ltd. - Overview
Exhibit 246: Jubilant Life Sciences Ltd. - Product / Service
Exhibit 247: Jubilant Life Sciences Ltd. - Key offerings
Exhibit 248: SWOT
Exhibit 249: Lupin Ltd. - Overview
Exhibit 250: Lupin Ltd. - Business segments
Exhibit 251: Lupin Ltd. - Key news
Exhibit 252: Lupin Ltd. - Key offerings
Exhibit 253: Lupin Ltd. - Segment focus
Exhibit 254: SWOT
Exhibit 255: Novartis AG - Overview
Exhibit 256: Novartis AG - Business segments
Exhibit 257: Novartis AG - Key news
Exhibit 258: Novartis AG - Key offerings
Exhibit 259: Novartis AG - Segment focus
Exhibit 260: SWOT
Exhibit 261: Pfizer Inc. - Overview
Exhibit 262: Pfizer Inc. - Product / Service
Exhibit 263: Pfizer Inc. - Key news
Exhibit 264: Pfizer Inc. - Key offerings
Exhibit 265: SWOT
Exhibit 266: Sanofi SA - Overview
Exhibit 267: Sanofi SA - Business segments
Exhibit 268: Sanofi SA - Key news
Exhibit 269: Sanofi SA - Key offerings
Exhibit 270: Sanofi SA - Segment focus
Exhibit 271: SWOT
Exhibit 272: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 273: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 274: Sun Pharmaceutical Industries Ltd. - Key news
Exhibit 275: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibit 276: SWOT
Exhibit 277: Teva Pharmaceutical Ltd. - Overview
Exhibit 278: Teva Pharmaceutical Ltd. - Business segments
Exhibit 279: Teva Pharmaceutical Ltd. - Key news
Exhibit 280: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 281: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 282: SWOT
Exhibit 283: Zydus Lifesciences Ltd. - Overview
Exhibit 284: Zydus Lifesciences Ltd. - Business segments
Exhibit 285: Zydus Lifesciences Ltd. - Key news
Exhibit 286: Zydus Lifesciences Ltd. - Key offerings
Exhibit 287: Zydus Lifesciences Ltd. - Segment focus
Exhibit 288: SWOT
Exhibit 289: Inclusions checklist
Exhibit 290: Exclusions checklist
Exhibit 291: Currency conversion rates for US$
Exhibit 292: Research methodology
Exhibit 293: Information sources
Exhibit 294: Data validation
Exhibit 295: Validation techniques employed for market sizing
Exhibit 296: Data synthesis
Exhibit 297: 360 degree market analysis
Exhibit 298: List of abbreviations
Executive Summary
The following companies are recognized as the key players in the global global vertigo drugs market: AdvaCare Pharma, Amneal Pharmaceuticals Inc., AstraZeneca Plc, Epic Pharma LLC, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Intas Pharmaceuticals Ltd., Jubilant Life Sciences Ltd., Lupin Ltd., Mallinckrodt Plc, Novartis AG, Pfizer Inc., Prestige Consumer Healthcare Inc., Sanofi SA, Sound Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Ltd., WellSpring Pharmaceutical Corp., Zydus Lifesciences Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is integration of digital health solutions in vertigo."
According to the report, one of the major drivers for this market is the rising demand for vertigo drugs in emerging economies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AdvaCare Pharma
- Amneal Pharmaceuticals Inc.
- AstraZeneca Plc
- Epic Pharma LLC
- F. Hoffmann La Roche Ltd.
- GlaxoSmithKline Plc
- Intas Pharmaceuticals Ltd.
- Jubilant Life Sciences Ltd.
- Lupin Ltd.
- Mallinckrodt Plc
- Novartis AG
- Pfizer Inc.
- Prestige Consumer Healthcare Inc.
- Sanofi SA
- Sound Pharmaceuticals
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Ltd.
- WellSpring Pharmaceutical Corp.
- Zydus Lifesciences Ltd.
